Literature DB >> 24812604

Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma.

Noemí Eiró1, Francisco J Vizoso1.   

Abstract

Hepatocellular carcinoma (HCC) is the third largest cause of cancer deaths worldwide. It seems to be needed to find new ways to address the mechanisms involved in the progression of HCC, which can provide a prognostic evaluation and new therapeutic targets. Several studies have established that crosstalk between tumor cells and the microenvironment plays a key role in tumor progression and metastasis. In this context, the work of Zhu et al. contributes to assess interactions between tumor and microenvironment associated-macrophages promoting tumor progression and metastasis. Indeed, they concluded that the interplay of osteopontin (OPN) and peritumoral macrophages (PTMs) represents a new insight into tumor progression and therapeutic targets for HCC. Historically, tumor-infiltrating leukocytes have been considered to be manifestations of an intrinsic defensive mechanism against developing tumors, however, now, it is know that that leukocytes infiltration can promote tumor phenotypes, such as angiogenesis, growth, and invasion. Characterization of functional heterogeneity of stromal cell components, and specifically the analysis of stromal fibroblasts can provide a new focus on mechanisms involved in the progression of HCC. All of this opens the possibility to provide prognostic information for HCC based on biological parameters derived from peritumoral status from tumors.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); fibroblasts; macrophages; tumor microenvironment

Year:  2014        PMID: 24812604      PMCID: PMC3999424          DOI: 10.3978/j.issn.2304-3881.2014.02.12

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  20 in total

1.  Tumor-associated macrophages: the double-edged sword in cancer progression.

Authors:  Jeremy J W Chen; Yi-Chen Lin; Pei-Li Yao; Ang Yuan; Hsang-Yu Chen; Chia-Tung Shun; Meng-Feng Tsai; Chun-Houh Chen; Pan-Chyr Yang
Journal:  J Clin Oncol       Date:  2004-12-14       Impact factor: 44.544

Review 2.  Soluble mediators of inflammation during tumor development.

Authors:  Stephen C Robinson; Lisa M Coussens
Journal:  Adv Cancer Res       Date:  2005       Impact factor: 6.242

Review 3.  Jekyll and Hyde: the role of the microenvironment on the progression of cancer.

Authors:  Michael Allen; J Louise Jones
Journal:  J Pathol       Date:  2010-10-29       Impact factor: 7.996

4.  Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.

Authors:  Noemí Eiró; Antonio Altadill; Luis M Juárez; Manuel Rodríguez; Luis O González; Sara Atienza; Sandra Bermúdez; Belen Fernandez-Garcia; Manuel F Fresno-Forcelledo; Luis Rodrigo; Francisco J Vizoso
Journal:  Hepatol Res       Date:  2013-07-10       Impact factor: 4.288

Review 5.  Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.

Authors:  Yoon Seok Roh; Ekihiro Seki
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 6.  Distinct role of macrophages in different tumor microenvironments.

Authors:  Claire E Lewis; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

Authors:  Neta Erez; Morgan Truitt; Peter Olson; Sarah Tuttleton Arron; Douglas Hanahan
Journal:  Cancer Cell       Date:  2010-02-04       Impact factor: 31.743

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 9.  The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.

Authors:  Paola Allavena; Antonio Sica; Cecilia Garlanda; Alberto Mantovani
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

10.  High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Authors:  Xiao-Dong Zhu; Ju-Bo Zhang; Peng-Yuan Zhuang; Hong-Guang Zhu; Wei Zhang; Yu-Quan Xiong; Wei-Zhong Wu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

View more
  8 in total

1.  Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Redha Al-Bahrani; Seishi Nagamori; Roger Leng; Anna Petryk; Consolato Sergi
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

Review 2.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

3.  Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma.

Authors:  Yuri Cho; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Chung Yong Kim; Jung-Hwan Yoon
Journal:  Dig Dis Sci       Date:  2016-04-13       Impact factor: 3.199

4.  Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.

Authors:  Chuang Chen; Hui Zhao; Xu Fu; LuoShun Huang; Min Tang; XiaoPeng Yan; ShiQuan Sun; WenJun Jia; Liang Mao; Jiong Shi; Jun Chen; Jian He; Jin Zhu; YuDong Qiu
Journal:  Oncotarget       Date:  2017-05-02

5.  Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.

Authors:  Rada Teodora Sufleţel; Carmen Stanca Melincovici; Bogdan Alexandru Gheban; Zaharie Toader; Carmen Mihaela Mihu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

6.  Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.

Authors:  Andrea M Müller; Kathrin A Schmohl; Kerstin Knoop; Christina Schug; Sarah Urnauer; Anna Hagenhoff; Dirk-André Clevert; Michael Ingrisch; Hanno Niess; Janette Carlsen; Christian Zach; Ernst Wagner; Peter Bartenstein; Peter J Nelson; Christine Spitzweg
Journal:  Oncotarget       Date:  2016-08-23

Review 7.  Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.

Authors:  Isabel Fabregat; Daniel Caballero-Díaz
Journal:  Front Oncol       Date:  2018-09-10       Impact factor: 6.244

8.  N6-methyladenosine associated prognostic model in hepatocellular carcinoma.

Authors:  Hanchun Huang; Yi Bai; Xin Lu; Yiyao Xu; Haitao Zhao; Xinting Sang
Journal:  Ann Transl Med       Date:  2020-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.